Chloroquine can no longer be recommended as the first-line treatment for falciparum malaria in several parts of Africa, given the increasing resistance of Plasmodium falcipanrm to this drug. The sulfadoxinepyrimethamine combination (SP) is obviously an alternative candidate, that has already been se
Low-dose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau
✍ Scribed by Poul-Erik Kofoed; Francisco Lopes; Peter Johansson; Francisco Dias; Anita Sandström; Peter Aaby; Lars Rombo
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 393 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
✦ Synopsis
The recommended dose of 10 mg quinine/kg bodyweight 3 times a day for 7 days for treatment of malaria is so high that many patients experience cinchonism. We have earlier obtained good results with 7 days' treatment with 20 mg Quinimax/kg bodyweight divided into 2 daily doses. In order to identify the lowest effective dose, children with symptomatic malaria were treated with quinine twice a day for 7 days. They were assigned to 1 of 3 groups treated daily with 10 mg/kg, 15 mg/kg, or 20 mg/kg bodyweight, respectively; 42, 46, and 34 children, respectively, received treatment and completed 5 weeks of follow-up. The cumulative percentages of all children with parasitaemia during follow-up on day 28 or before were 33%, 13% and 12%, respectively. Treatment with 10 mg quinine salt/kg daily for 7 days gave a significantly higher rate of recrudescence than did treatment with 15 or 20 mg/kg daily. Thus at least 15 mg of quinine salt/kg bodyweight daily should be recommended for treatment of symptomatic Plasmodium falciparum malaria in Guinea-Bissau.
📜 SIMILAR VOLUMES